Clinical Trial Update: ASC - Autism Study [Phase 1]

View source ↗

Summary

A Phase 1 autism study sponsored by Cell to Cure ApS using mesenchymal stromal cells has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Inflammatory Bowel Diseases

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Cell to Cure ApS | Conditions: Autism Spectrum Disorder, Gastrointestinal Dysfunction | Phase 1 | Status: COMPLETED